A Study of MODS in Dengue Fever with Emphasis on Comparison between Survivors & Non-Survivors

Authors

  • Kiran H S Associate Professor, Department of Internal Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India Author
  • Ravi Kumar Y S Professor, Department of Internal Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India Author
  • Subhaschandra B J Professor & HOD, Department of Internal Medicine, JSS Medical College and Hospital, JSSAHER, Mysore, Karnataka, India. Author

Keywords:

Dengue fever, Multi-organ failure (MOF), Multi-organ dysfunction syndrome(MODS)

Abstract

Background: Dengue is the most common mosquito-borne viral disease throughout the world. Dengue could be asymptomatic or it may  manifest as non-severe, severe and fatal types. Severe dengue manifests itself in myriad ways. Excessive hospitalization of dengue patients  occurs due to the absence of definite early prognostic markers or early predictors of severity/mortality. There are few Indian studies on  mortality in severe dengue. The objective of this study was to explore Multi-organ dysfunction syndrome (MODS) in Dengue fever with an  emphasis on comparison between survivors & non-survivors. Subjects and Methods: This study was done at JSS Hospital, a tertiary referral  teaching hospital of JSSMC, JSSAHER with 80 adult ICU beds. It was a retrospective observational study. Patients with laboratory-confirmed  severe dengue infections satisfying inclusion and exclusion criteria and admitted to the ICU between September 2016 and September 2017,  including the large outbreak period were considered. The data were collected from inpatient case-records and the analysis was done,  retrospectively. Results: A total of 29 patients met all inclusion and exclusion criteria. In our study, out of 29 cases, total number of males  were 17 (58.6%), whereas females were 12 (41.4%). Mean age of patients was 43.37 years (SD:14.36). The mortality of severe dengue with  MODS admitted to the ICU remains high (55.2%) in this study. In this study, mean age was more in survivors when compared to non  survivors; At admission, Creatinine, Lactate & PCV were higher among non survivors; All patients with Hypotension, Both the patients with  ARDS, myocarditis & All the 6 patients who had bleeding manifestations expired & prolonged a PTT and PT-INR were found among many  non survivors; Other parameters like LFT, Se.Albumin and Comorbidities did not have any impact on mortality. In this study, though both the  groups had hypoalbuminemia, Serum Albumin was not statistically significant between survivors & non-survivors while arterial Lactate,  creatinine and PCV were significant. Conclusion: The mortality of severe dengue with MODS admitted to the ICU remains high. In this study,  surprisingly, mean age was more in survivors when compared to non-survivors; Creatinine, Lactate & PCV were higher among non-survivors.  Other parameters like LFT, Se.Albumin and Comorbidities did not have any impact on mortality. Definite early prognostic markers or early  predictors of severity/mortality is the need of the day. 

Downloads

Download data is not yet available.

References

1. Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue:

past,present and future prospects. ClinEpidemiol 2013;5:299–309.

2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL,

et al.The global distribution and burden of dengue. Nature. 2013; 496:

504-507.

3. World Health Organization.What is dengue? Available

from:https://www.who.int/denguecontrol/disease/en/epidemiology[Las

t accessed on 2019 Jan 19].

4. Kamath S, Jain N, Gupta, Jha AC, Rao BS. Dengue Epidemic in

Jamshedpur-Tata Main Hospital (TMH) Experience. J Trop Dis

2015;3:159.

5. Guzman MG, Gubler DJ, Izquierdo A, Martinez E, Halstead S.

Dengue infection. Nat Rev Dis Primers. 2016; 16055.

6. Pan American Health Organization. Dengue: Guidelines for patient

care in the region of the America. 2nd edition. Washington DC: Paho.

2016.

7. Guzman MG, Harris E. Dengue. Lancet 2015;385:453–65.

8. Halstead SB. Dengue. Lancet 2007;370:1644–52.

9. Lee L K, Earnest A, Carrasco LR, Thein TL, Gan VC, Lee

VJ,etal.Safety and cost savings of reducing adult dengue

hospitalization in a tertiary care hospital in Singapore. Trans R Soc

Trop Med Hyg 2013; 107: 37–42.

10. Jog et al. Dengue infection with multiorgan dysfunction:-sofa score,

arterial lactate and serum albumin levels are predictors of outcome.

Intensive Care Medicine Experimental 2015 3(Suppl 1):A830.

11. Hsieh CC, Cia CT, Lee JC, Sung JM,Lee NY, Chen PL, et al. A

Cohort Study of Adult Patients with Severe Dengue in Taiwanese

Intensive Care Units: The Elderly and APTT Prolongation Matter for

Prognosis. PLoSNegl Trop Dis. 2017; 11(1): e0005270.

12. Karunakaran A, Ilyas WM, Sheen SF et al Risk factors of mortality

among dengue patients admitted to a tertiary care setting in Kerala,

India. J Infect Public Health 2014; 7:114–20.

13. Thanachartwet V, Wattanathum A, Oer-Areemitr N, Jittmittraphap A,

Sahassananda D, Monpassorn C, Desakorn V. Diagnostic accuracy of

peripheral venous lactate and the 2009 WHO warning signs for

identifying severe dengue in Thai adults: a prospective observational

study. BMC Infect Dis. 2016;16(1)

14. Jain S, Mittal A, Sharma SK, et al. Predictors of Dengue-Related

Mortality and Disease Severity in a Tertiary Care Center in North

India. Open Forum Infect Dis. 2017;4(2):ofx056.

Published

2019-08-30

How to Cite

A Study of MODS in Dengue Fever with Emphasis on Comparison between Survivors & Non-Survivors . (2019). Academia Journal of Medicine, 2(1), 8-11. https://medjournal.co.in/index.php/ajm/article/view/203